Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption.
Kochanek
P M
PM
University of Pittsburgh, School of Medicine, Department of Anesthesiology and Critical Care, Medicine and Pediatrics, PA 15261.
Melick
J A
JA
Schoettle
R J
RJ
Magargee
M J
MJ
Evans
R W
RW
Nemoto
E M
EM
D000818:Animals; D001381:Azepines / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects* / Q000502:physiology; D004224:Diterpenes; D046934:Ginkgolides; D007213:Indomethacin / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D014230:Triazoles / Q000494:pharmacology
D001381:Azepines; D004224:Diterpenes; D046934:Ginkgolides; D007783:Lactones; D010972:Platelet Activating Factor; D014230:Triazoles; C052518:WEB 2086; C045856:ginkgolide B; D007213:Indomethacin